ADIL Earnings Adial Pharmaceuticals, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | -1.48 | 2026-05-08 | 10-Q |
| FY 2025 | 2025-12-31 | -11.93 | 2026-03-05 | 10-K |
| Q3 2025 | 2025-09-30 | -0.45 | 2025-11-13 | 10-Q |
| Q2 2025 | 2025-06-30 | -0.49 | 2025-08-13 | 10-Q |
| Q1 2026 | 2025-03-31 | -8.52 | 2026-05-08 | 10-Q |
| FY 2025 | 2024-12-31 | -68.01 | 2026-03-05 | 10-K |
| Q3 2025 | 2024-09-30 | -2.57 | 2025-11-13 | 10-Q |
| Q2 2025 | 2024-06-30 | -2.50 | 2025-08-13 | 10-Q |
| Q1 2025 | 2024-03-31 | -2.19 | 2025-05-14 | 10-Q |
| FY 2024 | 2023-12-31 | -3.60 | 2025-03-04 | 10-K |
| Q3 2024 | 2023-09-30 | -2.86 | 2024-11-13 | 10-Q |
| Q2 2024 | 2023-06-30 | -1.66 | 2024-08-13 | 10-Q |
| Q1 2023 | 2023-03-31 | -0.11 | 2023-05-12 | 10-Q |
| FY 2023 | 2022-12-31 | -12.71 | 2024-04-01 | 10-K |
| Q3 2023 | 2022-09-30 | -9.94 | 2023-11-14 | 10-Q |
| Q2 2023 | 2022-06-30 | -7.24 | 2023-08-21 | 10-Q |
| Q1 2023 | 2022-03-31 | -0.13 | 2023-05-12 | 10-Q |
| FY 2022 | 2021-12-31 | -1.04 | 2023-03-30 | 10-K |
| Q3 2022 | 2021-09-30 | -0.76 | 2022-11-14 | 10-Q |
| Q2 2022 | 2021-06-30 | -0.55 | 2022-08-15 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.